High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study

Oncology Letters ◽

10.3892/ol.2011.449 ◽

2011 ◽

Vol 3 (1) ◽

pp. 61-65 ◽

Author(s):

MASATAKA SAWAKI ◽

MASAKI WADA ◽

YASUYUKI SATO ◽

YUTAKA MIZUNO ◽

HIRONOBU KOBAYASHI ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Phase Ii Study ◽

Metastatic Breast ◽

High Dose ◽

Line Treatment ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

A multicenter phase II study of epirubicin with low-dose trastuzumab as a first line treatment in Her-2 overexpressing metastatic breast cancer: preliminary results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80420-9 ◽

2006 ◽

Vol 4 (2) ◽

pp. 165

Author(s):

M. Zilli ◽

De Tursi ◽

C. Carella ◽

E. Ricevuto ◽

P. Marchetti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Multicenter Phase ◽

Her 2 ◽

First Line Treatment

Download Full-text

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-005-9030-x ◽

2005 ◽

Vol 95 (1) ◽

pp. 45-53 ◽

Author(s):

M. Venturini ◽

C. Bighin ◽

S. Monfardini ◽

F. Cappuzzo ◽

N. Olmeo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

P101 A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer

10.1016/s0960-9776(07)70161-3 ◽

2007 ◽

Vol 16 ◽

pp. S41

Author(s):

M. De Tursi ◽

C. Carella ◽

E. Ricevuto ◽

A. Gennari ◽

C. Orlandini ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Multicenter Phase ◽

Her 2 ◽

First Line Treatment

Download Full-text

Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer

Oncology Research and Treatment ◽

10.1159/000180915 ◽

2009 ◽

Vol 32 (1-2) ◽

pp. 18-24 ◽

Author(s):

Brigitte Mlineritsch ◽

Renate Schabel-Moser ◽

Johannes Andel ◽

Michael Fridrik ◽

Martin Moik ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Line Treatment ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

P319 Phase II study of high-dose toremifene as first line treatment of metastatic breast cancer in patients with adjuvant aromatase inhibitor-resistance

10.1016/s0960-9776(11)70257-0 ◽

2011 ◽

Vol 20 ◽

pp. S77-S78

Author(s):

M. Sawaki ◽

M. Wada ◽

Y. Sato ◽

Y. Mizuno ◽

H. Kobayashi ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii Study ◽

Metastatic Breast ◽

High Dose ◽

Line Treatment ◽

Aromatase Inhibitor Resistance ◽

Inhibitor Resistance ◽

First Line Treatment

Download Full-text

Weekly Docetaxel and Gemcitabine following Docetaxel plus Epirubicin or Vinorelbine as First-Line Treatment of Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Tumori Journal ◽

10.1177/030089160609200102 ◽

2006 ◽

Vol 92 (1) ◽

pp. 6-12 ◽

Author(s):

Alberto Riccardi ◽

Silvia Brugnatelli ◽

Marco Danova ◽

Monica Giordano ◽

Palma Pugliese ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer

Anti-Cancer Drugs ◽

10.1097/00001813-199803000-00002 ◽

1998 ◽

Vol 9 (3) ◽

pp. 203-208 ◽

Author(s):

Ute Klaassen ◽

Hansjochen Wilke ◽

Regina Weyhofen ◽

Andreas Harstrick ◽

Wilfried Eberhardt ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

High Dose ◽

Line Treatment ◽

First Line Treatment

Download Full-text

413 POSTER A multicenter phase II study of Epirubicin (E) with low-dose herceptin (LD-H) as a first line treatment in HER-2 overexpressing metastatic breast cancer (MBC): Preliminary results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80711-6 ◽

2005 ◽

Vol 3 (2) ◽

pp. 116

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Multicenter Phase ◽

Her 2 ◽

First Line Treatment

Download Full-text

Abstract PD1-03: A multicenter phase II study evaluating the efficacy of nivolumab plus paclitaxel plus bevacizumab triple-combination therapy as a first-line treatment in patients with HER2-negative metastatic breast cancer: WJOG9917B NEWBEAT trial

10.1158/1538-7445.sabcs19-pd1-03 ◽

2020 ◽

Author(s):

Yukinori Ozaki ◽

Toru Mukohara ◽

Junji Tsurutani ◽

Masato Takahashi ◽

Koji Matsumoto ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Triple Combination ◽

Triple Combination Therapy ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

Oncology ◽

10.1159/000086986 ◽

2005 ◽

Vol 68 (4-6) ◽

pp. 438-445 ◽

Author(s):

S. Palmeri ◽

M. Vaglica ◽

S. Spada ◽

G. Filippelli ◽

A. Farris ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text